% | $
Quotes you view appear here for quick access.

Rockwell Medical, Inc. Message Board

  • bioselector bioselector Jun 23, 2013 5:40 PM Flag

    All FINANCING in Place for FDA Approval & Rockwell set for Uptrending in Price.

    A $600 Million market for SFP and another $250 Million for Calcitriol.The Hemoglobin will be with-in parameters as it's now the Primary target for Phase 3 and reduces ESA USE BY 35% and a exceptional safety record.Would not worry about SFP and Calcitriol as both are in victory lane.Analyst price $15 and that a reasonable figure.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
6.23-0.21(-3.26%)Feb 5 4:00 PMEST